卢佩诺的分子动力学探索:对多种质母细胞瘤和阿尔茨海默氏症粉样β病原体的治疗影响
Hailah M Almohaimeed1, Amany I Almars2, Waleed Al Abdulmonem3
1Department of Basic Science, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia.
Metabolic brain disease
|December 22, 2023
概括
卢本通过向关键蛋白质,显示出治疗质母细胞瘤和阿尔茨海默病的前景. 建议进行进一步的研究,以验证其在临床环境中的治疗潜力.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
背景情况:
- 由于复杂的分子通路,质母细胞瘤和阿尔茨海默病存在重大治疗挑战.
- 新的治疗策略对于解决这些神经瘤和神经退行性疾病至关重要.
研究的目的:
- 调查卢佩的治疗潜力,一个植物成分,对质母细胞瘤和阿尔茨海默氏症的粉样β病理.
- 使用计算方法评估卢佩诺因与关键蛋白标 (5H08和2ZHV) 的相互作用.
主要方法:
- 采用综合方法,结合蛋白质组学和计算机辅助药物设计.
- 进行了分子对接和分子动力学模拟,以分析卢佩农蛋白相互作用.
- 研究了使用蛋白质溶解向奇默体 (PROTACs) 提高卢佩诺的功效的潜力.
主要成果:
- 卢本对5H08 (-9.54 kcal/mol) 和2ZHV (-10.59 kcal/mol) 呈现强烈的结合亲和力.
- 这些相互作用表明,Lupenone有潜力减轻质母细胞瘤和调节阿尔茨海默氏症的粉样β病理.
- PROTACs进一步增强了卢佩农的治疗前景.
结论:
- 卢本显示出基于in-silico发现的质母细胞瘤和阿尔茨海默病的显著治疗潜力.
- 这项研究为在未来的神经退行性和神经瘤学研究中考虑Lupenone提供了坚实的基础.
- 在体外环境中经验验证是有必要的,以探索Lupenone的全部治疗能力.
更多相关视频
相关概念视频
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...